Ireland lags behind other countries for speed of access to new medicines
A new study has revealed this country ranks 19th out of 34 European countries, with patients waiting an average of 521 days
Ireland ranks 19th out of 34 European countries for speed of access to new medicines, new data has revealed.
The study was carried out by health analysts IQVIA using the Wait indicator, which is produced by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
From 2015 to 2018, Irish patients were waiting an average of 521 days before their doctors could prescribe the latest reimbursable treatments for often serious medical conditions. The wait...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Potential use of rapid antigen tests in workplaces and schools to be assessed
Speedy tests for virus could be used alongside the state’s PCR testing programme as country aims for safer eventual reopening
‘The next few weeks will give us hope if we can hang in there’
There are still some clouds on the horizon with the threat of new variants, but there is also hope as health workers report real benefits from the rollout of the Covid-19 vaccines
Lifting of ban on visits to nursing homes now urged
Geriatric specialists say vaccination has reduced the risk hugely, and that leaving the elderly to die alone in homes is ‘inhumane’
Deforestation, the wildlife trade and intensive farming: a recipe for lethal virus outbreaks
Conditions in the Wuhan market may have been an ‘early amplifier’ of the Covid-19 virus. Habitat destruction, the intensification of agriculture, global travel and climate change will be among the main factors in the emergence of even more deadly diseases, experts warn, as ‘we push nature to its limit’
